CYP2E1 Polyclonal Antibody, RBITC Conjugated
Product Specifications
Background
Metabolizes several precarcinogens, drugs, and solvents to reactive metabolites. Inactivates a number of drugs and xenobiotics and also bioactivates many xenobiotic substrates to their hepatotoxic or carcinogenic forms.
Synonyms
CPE1; CYP2E; P450-J; P450C2E; Cytochrome P450 2E1; 4-nitrophenol 2-hydroxylase; CYPIIE1; Cytochrome P450-J; CYP2E1
Gene ID
1571
Swiss Prot
P05181
Cellular Locus
Cytoplasm, Cell membrane
Host
Rabbit
Cross Reactivity
Human, Mouse, Rat
Immunogen
401-493/493
Target
CYP2E1
Clonality
Polyclonal
Conjugation
RBITC
Source
KLH conjugated synthetic peptide derived from human CYP2E1
Applications
WB, IF (IHC-P), IF (IHC-F), IF (ICC)
Purification
Purified by Protein A.
Excitation Emission
570nm/595nm
Concentration
1ug/ul
Dilution
WB (1:300-5000), IF (IHC-P) (1:50-200), IF (IHC-F) (1:50-200), IF (ICC) (1:50-200)
Buffer
Aqueous buffered solution containing 0.01M TBS (pH7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol.
Modification
Unmodified
Storage Conditions
Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.
Prediction Reactivity
Dog, Cow, Sheep, Pig, Horse, Rabbit
Gene ID URL
1571
Isotype
IgG
More Discoveries
Explore Other Products
Browse additional items from our catalog
VC102581 10 µg
SARS-CoV-2 Nsp14 Gene Tagged ORF Clone (Native Sequence)
Sign In for Pricing
View Details 
ICH5967-10mg 10 mg (2x 5 mg)
Vantictumab Biosimilar - Research Grade
Sign In for Pricing
View Details 